Results 91 to 100 of about 6,803 (119)

Association of hepatic steatosis with increased plasma xanthine oxidoreductase activity: MedCity21 health examination registry. [PDF]

Metabol Open
Kurajoh M, Fukumoto S, Akari S, Nakamura T, Miki Y, Nagata Y, Morioka T, Mori K, Imanishi Y, Watanabe T, Emoto M.   +10 more
europepmc   +1 more source

Xanthine Oxidoreductase Inhibitor Use Associated With Reduced Risk of Sarcopenia and Severe Sarcopenia in Patients Undergoing Hemodialysis. [PDF]

Front Med (Lausanne), 2022
Kurajoh M, Mori K, Miyabe M, Matsufuji S, Kizu A, Tsujimoto Y, Emoto M.   +6 more
europepmc   +1 more source

Xanthine oxidoreductase expression is diminished in breast cancer as a response to uric acid mediated chelation of redox active iron. [PDF]

Free Radic Biol Med
Chapa MG, King RD, Dean ZW, Maskey A, Park RM, Velayutham M, Pugacheva EN, Woodward OM, Webb BA, Spitz DR, Kelley EE.   +10 more
europepmc   +1 more source

The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors. [PDF]

Oxid Med Cell Longev, 2021
Liu N, Xu H, Sun Q, Yu X, Chen W, Wei H, Jiang J, Xu Y, Lu W.   +8 more
europepmc   +1 more source

Xanthine Oxidoreductase Is Involved in Chondrocyte Mineralization and Expressed in Osteoarthritic Damaged Cartilage. [PDF]

Front Cell Dev Biol, 2021
Nasi S, Castelblanco M, Chobaz V, Ehirchiou D, So A, Bernabei I, Kusano T, Nishino T, Okamoto K, Busso N.   +9 more
europepmc   +1 more source

Influence of xanthine oxidoreductase inhibitor, topiroxostat, on body weight of diabetic obese mice. [PDF]

Nutr Diabetes, 2021
Nakamura T, Nampei M, Murase T, Satoh E, Akari S, Katoh N, Mizukami H.   +6 more
europepmc   +1 more source

Cardiovascular Events During Treatment With Xanthine Oxidoreductase Inhibitors in Patients With Gout and Hyperuricemia in Japan　- A JMDC Claims Database Study. [PDF]

Circ Rep
Kario K, Akari S, Kanegae H.
europepmc   +1 more source

Time-dependent changes in plasma xanthine oxidoreductase during hospitalization of acute heart failure. [PDF]

ESC Heart Fail, 2021
Okazaki H, Shirakabe A, Matsushita M, Shibata Y, Shigihara S, Sawatani T, Tani K, Kiuchi K, Otsuka Y, Murase T, Nakamura T, Kobayashi N, Hata N, Asai K, Shimizu W.   +14 more
europepmc   +1 more source

Allopurinol, Febuxostat, and Nonuse of Xanthine Oxidoreductase Inhibitor Treatment in Patients Receiving Hemodialysis: A Longitudinal Analysis. [PDF]

Kidney Med
Ishii T, Seya N, Taguri M, Wakui H, Yoshimura A, Tamura K.   +5 more
europepmc   +1 more source

Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes. [PDF]

J Diabetes Investig
Kitamura A, Kurajoh M, Miki Y, Kakutani Y, Yamazaki Y, Ochi A, Morioka T, Mori K, Shoji T, Emoto M.   +9 more
europepmc   +1 more source